Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
In the interim, NICE-approved options for weight management in adults with obesity include: Orlistat (available on NHS prescription) Semaglutide 2.4 mg (Wegovy) , recommended by NICE in 2023 for use in specific patient groups (NICE technology appraisal TA875) Tirzepatide (Mounjaro) , which received NICE approval in 2024 for obesity management (NICE technology appraisal TA1026) [18] Patients seeking advice about weight management or blood pressure control should be directed to their GP in the first instance, who can assess eligibility for currently approved treatments and refer to specialist services where appropriate
Am J Physiol Endocrinol Metab
Following is the table for Wegovy (semaglutide) dosing: Key Considerations Gradual Dose Increase: Helps reduce side effects like nausea and digestive discomfort
The oral drop option, despite limited evidence, serves people who truly cannot tolerate injections
US$ 27.52
US$ 27.40
US$ 27.40
